Search results
Earnings call: Invivyd optimistic about PEMGARDA's market potential
Investing.com· 17 hours agoInvivyd, a biotechnology company, recently held an earnings call to discuss their first-quarter...
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Zacks via Yahoo Finance· 12 hours agoDesigned to provide broad exposure to the Healthcare - Biotech segment of the equity market, the...
CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 3 days agoCollPlant Biotechnologies (CLGN) was a big mover last session on higher-than-average trading volume....
Earnings call: Adaptive Biotechnologies reports robust MRD growth By Investing.com
Investing.com· 5 days agoAdaptive Biotechnologies (NASDAQ:ADPT) has announced its financial results for the first quarter of...
EPA, USDA, and FDA to Clarify Overlapping Biotechnology Regulatory Frameworks
The National Law Review· 4 hours agoOn May 8, 2024, the U.S. Environmental Protection Agency (EPA), U.S. Department of Agriculture (USDA), and U.S. Food and Drug Administration (FDA) released a joint plan to identify areas of ...
Earnings call: Seres Therapeutics reports on Q1 2024 with VOWST updates By Investing.com
Investing.com· 4 hours agoSeres Therapeutics (NASDAQ:MCRB), a biotechnology firm focused on microbiome therapeutics, has...
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Invest In Growth?
Simply Wall St. via Yahoo Finance· 2 days agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...
Earnings call: Humacyte anticipates strong market entry post-FDA review By Investing.com
Investing.com· 5 hours agoHumacyte, Inc. (HUMA), a biotechnology company specializing in regenerative medicine, has recently...
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
WTNH-TV New Haven· 2 hours agoINOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and ...
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 6 days agoAdaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 5.71% and 0.78%,...